Implicity ILR ECG Analyzer vs ASSURE Wearable ECG

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 70/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
Implicity ILR ECG Analyzer
by Implicity
VS
ASSURE Wearable ECG
by Kestra Medical Technologies

AI Verdict

Tool A (Implicity) specializes in optimizing the remote monitoring and management of data from cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs), focusing on AI-driven analysis to reduce false positives and streamline workflows for existing implanted data. Tool B (Kestra) provides a wearable ECG device for continuous external heart rate monitoring and data collection, offering a non-invasive solution for at-risk cardiac patients requiring ongoing surveillance. While both operate in the remote cardiac monitoring space, they address different primary data sources and patient monitoring modalities.

Choose Implicity ILR ECG Analyzer if…

Choose Implicity ILR ECG Analyzer if your clinic manages a large volume of data from cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs) and aims to significantly reduce false positive alerts and streamline clinical workflows. This platform is ideal for optimizing the interpretation of complex device data, automating billing, and improving patient connectivity for those with existing implanted devices.

View Implicity ILR ECG Analyzer →

Choose ASSURE Wearable ECG if…

Choose ASSURE Wearable ECG if you require a non-invasive, continuous heart rate and ECG monitoring solution for at-risk cardiac patients who may not yet require or have an implantable device. This wearable technology is best suited for collecting reliable, long-term physiological trend data, even with patient movement, and providing timely alerts through a user-friendly, non-adhesive system.

View ASSURE Wearable ECG →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Implicity ILR ECG Analyzer ASSURE Wearable ECG
Pricing Contact vendor for pricing information. Contact for pricing.
Deployment Cloud-based / SaaS Wearable device, mobile application, and cloud-based remote patient data platform.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

ASSURE Wearable ECG

Tool B, with its SensorFit Garment and mobile application, emphasizes patient comfort and ease of use for data collection, which is a primary aspect of usability for a wearable device. While Tool A focuses on clinician workflow optimization, Tool B's design directly addresses the patient's experience with the physical device and data interaction.

Clinical Value

Implicity ILR ECG Analyzer

Tool A provides specific, quantifiable improvements in diagnostic accuracy and efficiency, such as reducing false positives by 79% for Medtronic ILRs while maintaining 99% sensitivity, and an 85% decrease in unnecessary AF alerts. These metrics directly translate to improved clinical efficiency and better focus on relevant patient events.

Pricing & Value

Tie

Both tools require direct contact for pricing information, making it impossible to compare their cost-effectiveness. Both are FDA-cleared, HIPAA compliant, and have BAAs, indicating similar foundational regulatory and security assurances.

Enterprise Readiness

Implicity ILR ECG Analyzer

Tool A offers features like 'Unified Device Data' to centralize and standardize data from all cardiac implantable devices, 'Smart Workflow Automation,' and a 'Dynamic Billing Engine' with 90%+ billing compliance. These capabilities are crucial for seamless integration and efficient operation within large healthcare enterprises.

Innovation

Implicity ILR ECG Analyzer

Tool A demonstrates significant innovation through its AI algorithms that drastically reduce false positives and unnecessary alerts, and its automated patient connectivity management that re-engages disconnected patients. These features address critical challenges in remote cardiac monitoring with measurable impact.

Support & Docs

ASSURE Wearable ECG

Kestra Medical Technologies (Tool B) explicitly mentions a 'Kestra Care Team' accessible 24/7 via a helpline and provides patient handbooks and user manuals for both patients and clinicians. Implicity (Tool A) mentions 'dedicated support teams' but is less specific about publicly available documentation or direct support channels.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Implicity ILR ECG Analyzer ASSURE Wearable ECG
Primary Monitoring Focus Cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs) Continuous heart rate monitoring and data collection via a wearable ECG device for at-risk cardiac patients
AI/Algorithm Technology AI-Powered ILR ECG Analyzer; AI-Driven Alert Management with FDA-cleared algorithms ASSURE Detection Algorithm with Quad Channel Processingu2122; Adaptive Patient Intelligenceu2122
False Positive Reduction Claim Reduces false positives by 79% for Medtronic ILRs Not specified
Sensitivity Claim Maintains 99% sensitivity for Medtronic ILRs Not specified
Data Centralization/Platform Centralizes and standardizes all cardiac implantable device data Kestra CareStation remote patient data platform for clinician review
Alert Management Details Filters alerts with FDA-cleared algorithms, highlighting clinically relevant events; 85% decrease in unnecessary AF alerts Alert-based notifications; Automatic episode storage
Workflow & Billing Automation Smart Workflow Automation; Automates billing workflows and reporting; Dynamic Billing Engine achieves 90%+ billing compliance Not specified
Patient Connectivity Features Automated SMS to reconnect 28% of disconnected patients within two days Not specified
Motion Artifact Filtering Not specified Adaptive Patient Intelligenceu2122 for filtering motion artifacts

Videos

Demos, reviews, and walkthroughs featuring Implicity ILR ECG Analyzer and ASSURE Wearable ECG.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Implicity ILR ECG Analyzer is designed for patients with existing cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs), focusing on optimizing the analysis and management of data from these devices. The ASSURE Wearable ECG is a non-therapeutic wearable device for continuous heart rate monitoring and data collection in at-risk cardiac patients, particularly those who have completed use of an ASSURE Wearable Cardioverter Defibrillator (WCD) or require external continuous monitoring.
Implicity ILR ECG Analyzer centralizes and standardizes data from various cardiac implantable electronic devices (CIEDs) and implantable loop recorders (ILRs) already present in patients. The ASSURE Wearable ECG collects continuous heart rate data via its proprietary SensorFit Garment with embedded ECG sensors, transmitting this data to a mobile application and cloud-based platform.
Implicity's AI-powered ILR ECG Analyzer reduces false positives by 79% for Medtronic ILRs while maintaining 99% sensitivity and decreases unnecessary AF alerts by 85% through FDA-cleared algorithms, highlighting clinically relevant events. The ASSURE Wearable ECG utilizes its ASSURE Detection Algorithm with Quad Channel Processing and Adaptive Patient Intelligence to filter motion artifacts, ensuring higher quality continuous heart rate monitoring data.
Implicity ILR ECG Analyzer significantly reduces false positives for Medtronic ILRs and decreases unnecessary AF alerts by 85% by filtering alerts with FDA-cleared algorithms, helping clinicians focus on true events. The ASSURE Wearable ECG provides automatic episode storage and alert-based notifications, allowing clinicians to review relevant events detected by its continuous monitoring system.
Implicity ILR ECG Analyzer offers smart workflow automation, real-time access to unified device data, automated billing workflows, reporting, and patient connectivity management, including SMS to reconnect disconnected patients. The ASSURE Wearable ECG integrates by providing alert-based notifications and physiologic trend data via the Kestra CareStation remote patient data platform for clinician review, focusing on the data collected from its wearable device.
Implicity ILR ECG Analyzer is a cloud-based SaaS platform that analyzes data from existing implanted devices, meaning patient interaction is primarily with their implanted device and the remote monitoring service. The ASSURE Wearable ECG is a physical, non-adhesive wearable garment with embedded sensors that patients wear for continuous monitoring, directly interacting with the device and its associated mobile application.

More Comparisons

Assert-IQ vs Rapid Enterprise Platform
AISAP Cardio vs Rapid Enterprise Platform
AngioWaveNet vs Rapid Enterprise Platform
CorVista System with PH Add-On vs Rapid Enterprise Platform

More matchups featuring Implicity ILR ECG Analyzer or ASSURE Wearable ECG

Backers

Who funded each tool's parent company.

Implicity ILR ECG Analyzer

ASSURE Wearable ECG

AI Tool Finder
AI-powered search. Results may not be comprehensive.